John Teijaro

19PUBLICATIONS
132CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 06, 2026
Munc13-4-STX7 inhibitors impair endosomal TLR activation and systemic inflammation.

Jennifer L Johnson, Elsa Meneses-Salas, Aparna Shukla

|Jan 28, 2026
Integrated phenotypic screening and chemical proteomics identifies ETF1 ligands that modulate viral translation and replication.

Arthur S Kim, Kevin Ma, Christopher J Reinhardt

|Jan 23, 2026
Beyond suppression: the paradox of JAK inhibitors as amplifiers of cancer immunotherapy.

Jaroslav Zak, John R Teijaro

|Nov 04, 2024
ISG15 Drives Immune Pathology and Respiratory Failure during Systemic Lymphocytic Choriomeningitis Virus Infection.

Namir Shaabani, Jaroslav Zak, Jennifer L Johnson

|Oct 04, 2024
Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy.

Yingqin Hou, Jaroslav Zak, Yujie Shi

|Jul 03, 2024
PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections.

Ryan M Shepard, Anghesom Ghebremedhin, Isaraphorn Pratumchai

Pageof 4

Frequent Collaborators

7 joint publications

Jaroslav Zak

4 joint publications

Namir Shaabani

4 joint publications

Daniel Lazar

4 joint publications

Dennis R Burton